Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bioconjugate chemistry

• Publication date

  2005-10-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BC050217OPMID 16287248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor.

  2005cited by this paper
• The blood-brain barrier: an overview: structure, regulation, and clinical implications.

  2004cited by this paper
• Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.

  2004cited by this paper
• Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat

  2002cited by this paper
• Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting

  2002cited by this paper
• Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

  2001cited by this paper
• Polysaccharide colloidal particles as delivery systems for macromolecules.

  2001cited by this paper
• Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia

  2001cited by this paper
• Chitosan-based nanoparticles for topical genetic immunization.

  2001cited by this paper
• Nanoparticulate systems for brain delivery of drugs.

  2001cited by this paper
• Chitosan-Gadopentetic Acid Complex Nanoparticles for Gadolinium Neutron-Capture Therapy of Cancer: Preparation by Novel Emulsion-Droplet Coalescence Technique and Characterization

  1999cited by this paper
• Induction of Caspase-3-Like Protease May Mediate Delayed Neuronal Death in the Hippocampus after Transient Cerebral Ischemia

  1998cited by this paper
• Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines

  1997cited by this paper
• The Blood‐brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System

  1996cited by this paper
• Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)

  1994cited by this paper
• Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics.

  1994cited by this paper
• Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.

  1992cited by this paper
• Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

  1991cited by this paper
• Human blood-brain barrier transferrin receptor.

  1987cited by this paper
• Transferrin receptor on endothelium of brain capillaries

  1984cited by this paper

• Chitosan nanoparticles for brain targeted nose-to-brain drug delivery in neurodegenerative disease: a comprehensive exploration of advances, limitations and future prospects.

  2026cites this paper
• Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations.

  2025cites this paper
• Nanotechnology-Based Delivery of CRISPR/Cas9 for Cancer Treatment: A Comprehensive Review

  2025cites this paper
• Fabrication and optimization of verapamil-loaded PEGylated nanoparticles for management of traumatic brain injury: a comparative evaluation

  2025cites this paper
• Cell membrane-coated nanoparticles: a biomimetic strategy for effective treatment of ischemic stroke

  2025cites this paper
• Nanoparticle-Delivered Rutin Prevents Metabolic and Oxidative Imbalance in Obesity Triggered by a High-Fat Diet: In Vivo and In Silico Studies

  2025cites this paper
• Recent advances in potential drug nanocarriers for CNS disorders: a review

  2025cites this paper
• Recent Advances on Chitosan-Based Nanoparticles for Brain Drug Delivery

  2025cites this paper
• Exploring chitosan nanoparticles for enhanced therapy in neurological disorders: a comprehensive review

  2024cites this paper
• Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

  2024cites this paper
• An Overview of Various Approaches for Brain Targeted Drug Delivery System

  2024cites this paper
• A journey through the history of PEGylated drug delivery nanocarriers

  2024cites this paper
• A review of chitosan polysaccharides: Neuropharmacological implications and tissue regeneration.

  2024cites this paper
• Targeting Remyelination in Spinal Cord Injury: Insights and Emerging Therapeutic Strategies

  2024cites this paper
• Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases.

  2023cites this paper
• Biopolymers as promising vehicles for drug delivery to the brain

  2023cites this paper
• Current Strategy of Monoclonal Antibody: Development, Cloning, Formulation and Drug Delivery.

  2023cites this paper
• Precision Medicines for Retinal Lipid Metabolism-Related Pathologies

  2023cites this paper
• Preparation, characterization, and evaluation of antibacterial and cytotoxic activity of chitosan-polyethylene glycol nanoparticles loaded with amoxicillin as a novel drug delivery system

  2023cites this paper
• Comparative effects of curcumin versus nano-curcumin on histological, immunohistochemical expression, histomorphometric, and biochemical changes to pancreatic beta cells and lipid profile of streptozocin induced diabetes in male Sprague–Dawley rats

  2023cites this paper
• The Role of Nanotechnologies in Brain Tumors.

  2023cites this paper
• Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas

  2023cites this paper
• Improvement of synaptic plasticity by nanoparticles and the related mechanisms: Applications and prospects.

  2022cites this paper
• Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment.

  2022cites this paper
• Role of nanomaterials with special reference to pharmaceutical technology

  2022cites this paper
• Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.

  2022cites this paper
• Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats

  2022cites this paper
• Bioengineered nanogels for cancer immunotherapy.

  2022cites this paper
• Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release

  2021cites this paper
• Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumors.

  2021cites this paper
• Ways to enhance the bioavailability of polyphenols in the brain: A journey through the blood-brain barrier

  2021cites this paper
• Clofazimine functionalized polymeric nanoparticles for brain delivery in the tuberculosis treatment.

  2021cites this paper
• Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach.

  2021cites this paper
• Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders.

  2021cites this paper
• Antibody-Mediated Drug Delivery.

  2021cites this paper
• Chitin and chitosan

  2021cites this paper
• Modified biopolymer-based systems for drug delivery to the brain

  2021cites this paper
• Nano drug delivery systems in upper gastrointestinal cancer therapy

  2020cites this paper
• Nanomaterials for spinal cord injury (SCI) regeneration

  2020cites this paper
• Biodegradable Polymeric Nanoparticles for Brain-Targeted Drug Delivery

  2020cites this paper
• PEGylated chitin and chitosan derivatives

  2020cites this paper
• Polymeric Nanoparticles for Drug Delivery

  2020cites this paper
• Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers

  2020cites this paper
• Tissue Acidosis Associated with Ischemic Stroke to Guide Neuroprotective Drug Delivery

  2020cites this paper
• Chitosan as a machine for biomolecule delivery: A review.

  2020cites this paper
• Key for crossing the BBB with nanoparticles: the rational design

  2020cites this paper
• Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows

  2020cites this paper
• Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System

  2020cites this paper
• Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems

  2020cites this paper
• Novel amphiphilic chitosan micelles as carriers for hydrophobic anticancer drugs.

  2020cites this paper
• Understanding the Monoclonal Antibody involvement in Targeting the Activation of Tumor Suppressor Genes.

  2020cites this paper
• Panoramic View of Biological Barricades and Their Influence on Polysaccharide Nanoparticle Transport: An Updated Status in Cancer

  2020cites this paper
• Ultrathin Silicon Membranes for In Situ Optical Analysis of Nanoparticle Translocation across a Human Blood-Brain Barrier Model.

  2020cites this paper
• Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics

  2020cites this paper
• Dual effect of chitosan-based nanoparticles on the inhibition of β-amyloid peptide aggregation and disintegration of the preformed fibrils

  2019cites this paper
• Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab.

  2019cites this paper
• The Advances of Biomacromolecule-based Nanomedicine in Brain Disease

  2019cites this paper
• Chitosan-Based Nanocarriers for Nose to Brain Delivery

  2019cites this paper
• Application of Chitosan-Based Formulations in Controlled Drug Delivery

  2019cites this paper
• Nanopharmaceuticals: A Boon to the Brain-Targeted Drug Delivery

  2019cites this paper
• New phosphazene nanospheres anchored Fe(III), Co(II) and Cu(II) Schiff base complexes as efficient catalysts in oxidation of phenol

  2019cites this paper
• Insulin-coated gold nanoparticles as an effective approach for bypassing the blood-brain barrier

  2019cites this paper
• Chitosan nanoparticles release nimodipine in response to tissue acidosis to attenuate spreading depolarization evoked during forebrain ischemia.

  2019cites this paper
• Receptor-mediated transportation through BBB

  2019cites this paper
• The Strategies of Nanomaterials for Traversing Blood-Brain Barrier

  2019cites this paper
• Nanotechnology Based Diagnostics and Therapy for Pathogens- Related Infections in the CNS.

  2019cites this paper
• Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.

  2019cites this paper
• Spinal Cord Injury (SCI) Repair Strategies

  2019cites this paper
• Nano-Based Carriers for Brain Drug Delivery

  2019cites this paper
• Multidisciplinary Role of Mesoporous Silica Nanoparticles in Brain Regeneration and Cancers: From Crossing the Blood–Brain Barrier to Treatment

  2019cites this paper
• The development of a rabies virus glycoprotein derivative for targeted nanoparticulate drug delivery across an in vitro blood brain barrier model

  2019cites this paper
• Targeting the transferrin receptor for brain drug delivery.

  2019cites this paper
• Design of polymeric vectors for genetic manipulation

  2019cites this paper
• Sustainable Agriculture Reviews 36: Chitin and Chitosan: Applications in Food, Agriculture, Pharmacy, Medicine and Wastewater Treatment

  2019cites this paper
• A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles

  2019influential citation
• Polymeric Nanomedicine

  2019cites this paper
• Nanocarriers Used Most in Drug Delivery and Drug Release: Nanohydrogel, Chitosan, Graphene, and Solid Lipid

  2019cites this paper
• Chitosan and chitosan coating nanoparticles for the treatment of brain disease

  2019cites this paper
• 1 Comparative In Vitro Studies on PBN Loaded Nanoparticles Prepared by Biodegradable 1 Chitosan , PLGA Polymers and Their PEGylated Block Copolymers 2 3

  2018cites this paper
• Targeted Theranostic Nanoparticles for Brain Tumor Treatment

  2018cites this paper
• Targeting central nervous system pathologies with nanomedicines

  2018cites this paper
• Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression

  2018cites this paper
• Biologically-Derived Nanomaterials for Targeted Therapeutic Delivery to the Brain

  2018cites this paper
• Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides.

  2018cites this paper
• Research paper

  2018cites this paper
• Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles.

  2018cites this paper
• Nanoparticle‐Based Therapeutics for Brain Injury

  2018cites this paper
• Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy.

  2018cites this paper
• Cisplatin-Mediated Formation of Polyampholytic Chitosan Nanoparticles with Attenuated Viscosity and pH-Sensitive Drug Release.

  2017cites this paper
• Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells

  2017cites this paper
• Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes

  2017cites this paper
• Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders.

  2017cites this paper
• Synthesis and Characterization of PEGylated and Fluorinated Chitosans: Application to the Synthesis of Targeted Nanoparticles for Drug Delivery.

  2017cites this paper
• Surface properties and morphology of mixed POSS-DPPC monolayers at the air/water interface.

  2017cites this paper
• Nanomaterial applications for neurological diseases and central nervous system injury

  2017cites this paper
• Intranasal delivery of tapentadol hydrochloride–loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation

  2017influential citation
• Nano carriers for drug transport across the blood–brain barrier

  2017cites this paper
• The Medical Applications of Nanomaterials in the Central Nervous System

  2017cites this paper
• Tissue perfusion modelling in optical coherence tomography

  2017cites this paper
• Receptor Targeted Polymeric Nanostructures Capable of Navigating across the Blood-Brain Barrier for Effective Delivery of Neural Therapeutics.

  2017cites this paper